Mayo Clinic has a bold vision for the future of health care: more cures, better connections and enhanced care delivery that reaches more people – anytime, anywhere. With the Mayo Clinic Platform, we are bringing the best of Mayo Clinic to the world.
This virtual event premiered Thursday, August 5, 2021
The health care industry is ripe for transformation. For too long, health care has been reactive, inconvenient, unaffordable and inaccessible. Mayo Clinic Platform has emerged as a key driver in creating the next generation of health care at Mayo Clinic and beyond. Through Mayo Clinic Platform, we are embracing innovations in data and digital technologies to advance health care by leaps and bounds – and provide patient-centered solutions in ways that only Mayo Clinic can.
Dr. Farrugia, president and chief executive officer of Mayo Clinic, leads the No. 1-ranked hospital by U.S. News & World Report and one of the largest not-for-profit academic health systems in the U.S. With a 70,000-person workforce and $14 billion in annual revenues, Mayo Clinic cares for more than 1.2 million people each year with serious or complex illnesses from all 50 U.S. states and nearly 140 countries.
Dr. Farrugia is the John H. Noseworthy, M.D., and Jay Alix Distinguished Chair.
As president of the Mayo Clinic Platform, Dr. Halamka leads a portfolio of platform initiatives focused on transforming health care by leveraging artificial intelligence, connected health care devices and a network of trusted partners. Trained in emergency medicine and medical informatics, he has been developing and implementing health care information strategy and policy for more than 25 years.
Dr. Halamka is recognized with the distinction of the Michael D. Brennan, M.D., President’s Strategic Initiative Professorship.
Dr. Galanis is a consultant in the Department of Oncology with a joint appointment in the Department of Molecular Medicine at Mayo Clinic in Rochester, Minnesota. She serves as executive dean of Development. Dr. Galanis is an accomplished oncologist and virology researcher who has expanded the field of virotherapies for cancer.
She is a professor of oncology and the Sandra J. Schulze Professor of Novel Therapeutics, and she was honored with the Mayo Clinic Distinguished Investigator award.
Dr. Haddad is a consultant in the Department of Oncology at Mayo Clinic in Rochester, Minnesota, and serves as medical director of Care Anyplace, Center for Digital Health, and chair of Practice Innovation and Platform, Mayo Clinic Cancer Center.
In the field of digital health, Dr. Haddad's interest is in the transformation of health care delivery models with novel connected health and AI technology solutions. She's using Mayo Clinic Platform technology to develop better tools for assessing a person's risk of developing breast cancer.
Dr. Kapa is a consultant in the Division of Heart Rhythm Services, Department of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota. He serves as the lead for innovation related to virtual and augmented reality at Mayo Clinic and the medical director for artificial intelligence in knowledge management and delivery.
Dr. Kapa is highly sought after for his views on the future of digital health. He has filed more than 30 patents related to noninvasive carbon beam ablation and artificial intelligence algorithms.
Dr. Laack is a consultant and chair of the Department of Radiation Oncology at Mayo Clinic in Rochester, Minnesota. She is working to improve outcomes for patients diagnosed with pediatric and adult central nervous system tumors and sarcomas. Dr. Laack uses new imaging techniques to evaluate treatment responses and help guide therapy decisions. Through the Mayo Clinic Platform, Dr. Laack is using artificial intelligence to improve the quality and efficiency of creating radiation plans for cancer patients.
Dr. Paulson is a consultant in Hospital Medicine at Mayo Clinic Health System in Menomonie, Wisconsin, and the medical director of Mayo Clinic’s advanced care at home program for Northwest Wisconsin. Dr. Paulson is an advocate for providing health care to those most marginalized in society. The advanced care at home program allows her to call upon her experience in both acute and post-acute care to expand high-quality health care in transformational ways for Mayo Clinic.
Mayo Clinic’s commitment – the needs of the patient come first – has never been more relevant than it is today. The trust that patients have placed in Mayo inspires us to step forward on their behalf and lead the march of medical discovery and health care delivery into the digital age.
Through the platform, we will crystallize what is best about Mayo Clinic in a digital form and make it available to the world. Our bold vision, a strong strategy and a trusted reputation uniquely position us to lead this work. But we can’t do it without philanthropy. With the support of visionary benefactors, we will move forward with strength and innovation. With your support, we will lead the transformation of health care and improve the health of people everywhere.
The virtual care venture creates remote offerings that are both personalized and seamless across the patient care continuum. The advanced care at home program is designed for acute and complex patients. It will revolutionize their care through the provision of high-quality hospital services in the home.
The explosion of biomedical data has outpaced human ability to consume and understand it. With the data analytics venture, Mayo will apply artificial intelligence and other cutting-edge data science tools to biomedical data to improve patient health through powerful new insights and knowledge.
Using tools like remote monitoring devices for conditions such as heart arrhythmia will help us predict when a person may have an adverse event well before it happens. In times of crisis, it will help us to quickly respond with new treatments.